Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05731557 · ClinicalTrials.gov registry record
ACE, Resilience, and Substance Use Disorder: Maternal and Baby Outcomes in the First Year of Life
A clinical trial of Adverse Childhood Experiences, sponsored by The Cooper Health System.
- Completed
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT05731557: Completed study of Adverse Childhood Experiences, sponsored by The Cooper Health System.
NCT05731557 is a study of Adverse Childhood Experiences that has completed, run by The Cooper Health System. The registered enrollment target is 120 participants, below the 321-participant average among 13 other Adverse Childhood Experiences trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05731557, a study of Adverse Childhood Experiences, has completed, sponsored by The Cooper Health System.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand maternal factors, including ACE and 7Cs Tool scores, and how they contribute to the health of mothers and their infant. The study will evaluate whether or not the outcomes of maternal and baby health can be identified early through the Adverse Childhood Experiences (ACE) questionnaire, 7Cs Tool questionnaire, and Maternal Health Questionnaire. Additionally, the study will ask questions regarding current maternal social factors that could influence labor and delivery.
Primary Outcome
Emergency Room Visits over the first year will be evaluated at 12 months after the child's birth and will note the number of emergency room visits during the year.
Conditions Studied
Study Locations (1)
New Jersey
- Cooper University Hospital - Camden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2020-08-03 |
| Est. Completion | 2024-10-05 |
What the finished NCT05731557 record still lists
NCT05731557 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 321-participant average among 13 other Adverse Childhood Experiences trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Adverse Childhood Experiences appearing as the primary indexed condition, and to 0 interventions.
NCT05731557 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT05731557 about?
NCT05731557 is a clinical study titled "ACE, Resilience, and Substance Use Disorder: Maternal and Baby Outcomes in the First Year of Life". The purpose of this study is to understand maternal factors, including ACE and 7Cs Tool scores, and how they contribute to the health of mothers and their infant. The study will evaluate whether or not the outcomes of maternal and baby health can be identified early through the Adverse Childhood Exp...
What is the current status of trial NCT05731557?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2020-08-03. Estimated completion is 2024-10-05.
What conditions does trial NCT05731557 study?
This clinical trial studies the following conditions: Adverse Childhood Experiences.
Who is sponsoring clinical trial NCT05731557?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05731557 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adverse Childhood Experiences
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05731557's enrollment target sits among peer trials
120 7th of 13 higher than 7 of 13 other Adverse Childhood Experiences trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Adverse Childhood Experiences trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
The THRIVE Study: Teaching Healthy Regulation in Individuals & Vulnerable Environments
RECRUITING · NA
-
ACEs, SIRT1, and Premature Vascular Aging in Humans
RECRUITING · NA
-
School Violence Exposure as an Adverse Childhood Experience
RECRUITING
-
Building Resilient Families
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI